Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CARLSBAD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

RUBICON

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

GALT PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text

VPNA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 39
  • 0 comments

FDA approve ETODOLAC

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve NABUMETONE

Comment Full text

NATCO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve ETODOLAC

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve NABUMETONE

Comment Full text

ABRAXEOLUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 36
  • 0 comments

FDA approve ETODOLAC

Comment Full text

NATCO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 36
  • 0 comments

FDA approve ETODOLAC

Comment Full text
  • Previous
  • 252
  • 253
  • 254
  • 255
  • 256
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122402)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin